title: MicroRNA regulation of RAD51 in serous ovarian cancer modulates chemotherapy response.
authors.affiliation: Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands e.wiemer@erasmusmc.nl.
authors.forename: Erik A C
authors.initials: EA
authors.lastname: Wiemer
authors.affiliation: Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: Els M J J
authors.initials: EM
authors.lastname: Berns
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D018284:Cystadenocarcinoma, Serous / Q000188:drug therapy*; D004249:DNA Damage / Q000187:drug effects*; D004273:DNA, Neoplasm / Q000187:drug effects*; D005260:Female; D006801:Humans; D035683:MicroRNAs / Q000494:pharmacology*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D051135:Rad51 Recombinase / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D035683:MicroRNAs; D051135:Rad51 Recombinase